Search results for: 'Cancer Diagnostics Market, liquid biopsy'

The increase in HIV awareness among people has led to the demand for effective diagnostic products and solutions. As a result, some new products based on NAT technology and non-NAT technology platforms are being developed. This research service analyses the HIV diagnostics market in Europe, particularly, HIV NAT diagnostics and HIV Immunodiagnostic...

This study covers three countries in East Africa: Kenya, Uganda, Tanzania and their clinical diagnostics industry. Market, examining drivers and restraints for growth, pricing, distribution, technology, legislation, demand and geographical trends. Following from these, market growth for regional and market segments are forecasted. In addition, an i...

This research service focuses on the market for such therapeutics. It aims to introduce market opportunity for breast cancer therapeutics in the United States, and the top seven markets in Europe (Germany, France, the United Kingdom, Spain, Italy, Benelux and Scandinavia). For the purpose of analysis, a market forecast for the total world breast ca...

The unmet need to develop cost-effective diagnostic tests to distinguish acute and chronic hepatits cases has created an opportunity among market participants. This research service analyses the Hepatitis B and C diagnostics markets in Europe, particularly, Hepatitis B NAT diagnostics, Hepatitis B Immunodiagnostics, Hepatitis C NAT diagnostics and ...

The IVD market constantly changing. Mega Trends such as consolidation, automation, and reimbursement policies affect every aspect of the market. This study looks at the effects of these trends on three global consumer segments: hospitals, laboratories, and patients. The growing importance of diagnostics in patient care is expanding beyond hospitals...

This study addresses the current shift from in-hospital settings to non-hospital or outpatient settings for medical imaging service providers in the US and EU. The focus is on X-ray, ultrasound, mammography, MRI, and imaging IT solutions delivered in outpatient settings, such as ambulatory surgery centers (ASCs), independent imaging diagnostic cent...

The total market, as defined by this study, includes automated robotic workstations, low-to-mid throughput automated tools, and manual pipettes and consumables in the United States. The study period runs from 2011 to 2021, with 2014 as base year of 2014 and 20152021 as forecast period. This research service offers a discussion of the key market dr...

01 Jul 2015  |  North America  |  Market Research

Analysis of the US and European Diabetes Diagnostics Market

Constricting Reimbursement Policies Restrain Market Growth

Infographics

×

The diabetes diagnostics markets in the United States and Europe have been in a mature stage for many years. Growth is sustained due to the high prevalence of diabetes in both regions. The segments covered in the study are self-monitoring of blood glucose (SMBG), point-of-care testing (POCT), and lab-based HbA1c testing. The emerging market of non-...

15 Apr 2021  |  Global  |  Technology Research

Advanced Micro- and Nanofluidics Revolutionizing the Point of Care Diagnostic Industry

Disruptive microfluidic technologies enabling decentralization of diagnostic tests

Infographics

×

Microfluidics which manipulate small volumes of fluid in microchannels enable gentle manipulation of cells and molecules and precise control of experimental conditions. It allows miniaturization of bulk assays in small devices requiring small volumes of samples and reagents and integration of several components for multiplexing analysis and achievi...